| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3361234 | International Journal of Antimicrobial Agents | 2006 | 4 Pages |
Abstract
An initiative was taken to determine the in vitro activity of daptomycin against 85 Gram-positive isolates with reduced susceptibilities to linezolid and quinupristin/dalfopristin. Daptomycin had potent activity against all strains, with a Staphylococcus spp. minimum inhibitory concentration (MIC) ≤2 μg/mL and an Enterococcus spp. MIC ≤8 μg/mL. Resistance to linezolid and quinupristin/dalfopristin appears to be independent of reduced susceptibility to daptomycin.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Diane M. Anastasiou, Grace M. Thorne, Steven A. Luperchio, Jeff D. Alder,